Location: Toronto, Ontario, Canada
CIK: 0001484047 · Show all filings
Period: Q4 2013 (← Previous) (Next →)
Filing Date: Feb 5, 2014
Total Value: $1.166B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | EXPRESS SCRIPTS INC | 1,399,002 | $105M | 9.0% | $62.16 | — | Common Stock | 30219G108 |
| AMCX | AMC NETWORKS INC | 1,313,917 | $95.61M | 8.2% | $65.09 | +2.3% | Common Stock | 00164V103 |
| — | AON CORP | 1,062,160 | $95.2M | 8.2% | $66.62 | — | Common Stock | G0408V102 |
| MCO | MOODY'S CORP | 1,119,302 | $93.84M | 8.0% | $53.34 | +20.9% | Common Stock | 615369105 |
| WEX | WEX INC | 862,905 | $91.3M | 7.8% | $74.65 | +25.8% | Common Stock | 96208T104 |
| CACC | CREDIT ACCEPTANCE CORP | 640,491 | $88.95M | 7.6% | $108.70 | +11.7% | Common Stock | 225310101 |
| — | CHARTER COMMUNICATIONS | 597,711 | $87.33M | 7.5% | $124.32 | — | Common Stock | 16117M305 |
| ORCL | ORACLE CORP | 2,030,154 | $82.98M | 7.1% | $27.61 | +4.3% | Common Stock | 68389X105 |
| — | VALEANT PHARMACEUTICALS | 693,381 | $81.4M | 7.0% | $100.76 | — | Common Stock | 91911K102 |
| OMC | OMNICOM GROUP INC | 986,119 | $78.35M | 6.7% | $41.32 | +11.8% | Common Stock | 681919106 |
| — | CATAMARAN CORP | 1,286,199 | $65.22M | 5.6% | $47.64 | — | Common Stock | 148887102 |
| — | WELLS FARGO & CO | 3,714,986 | $63.11M | 5.4% | $13.94 | — | *W EXP 10/28/2018 | 949746119 |
| — | COMCAST CRP CL-A SPEC | 1,010,899 | $53.87M | 4.6% | $39.97 | — | Class A Shares | 20030N200 |
| — | EXPRESS SCRIPTS INC | 708,800 | $49.79M | 4.3% | $62.16 | — | Call | 30219G108 |
| — | AON CORP | 355,300 | $29.81M | 2.6% | $66.62 | — | Call | G0408V102 |
| — | DFC GLOBAL CORP | 400,000 | $4.58M | 0.4% | — | — | Call | 23324T107 |